Gelteq Statistics
NASDAQ: GELSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.5488-0.0111 (-1.98%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Gelteq by the numbers
Gelteq has a market capitalization of $5.9 million based on 10.71M shares outstanding. With trailing EPS of $-0.44, Gelteq is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.6% below its 50-day average and 20.9% below its 200-day average.
Average daily trading volume is 2.86M shares, or about $1.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GELS valuation vs. peer median
| Metric | GELS | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.88M | $5.87M | +0% |
| Avg. volume | 2.86M | 189.35K | +1412% |
Peer median across 8 companies: IMNN, CANF, KALA, SCNX, PULM, ADXN, ALZN, ENLV.
Valuation
- Market cap
- $5.88M
- EPS (TTM)
- $-0.44
- Shares outstanding
- 10.71M
Price and trading
- Previous close
- 0.5599
- Open
- 0.5485
- Day range
- 0.54 – 0.5525
- 52-week range
- 0.387 – 2.01
- 200-day moving average
- 0.6934
- Beta
- —
- Volume
- 17.66K
- Average volume
- 2.86M
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 5.88M
- Eps
- -0.44
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.01
- Week52 Low
- 0.39
- Avg Volume
- 2.86M
- Shares Outstanding
- 10.71M
- Ma50
- 0.59
- Ma200
- 0.69
- Pct From52w High
- -72.70%
- Pct From52w Low
- 41.81%